Epidemiology of hepatitis C virus infection in a country with universal access to direct‐acting antiviral agents: Data for designing a cost‐effective elimination policy in Spain-Reference-Cited by-同舟云学术

Epidemiology of hepatitis C virus infection in a country with universal access to direct‐acting antiviral agents: Data for designing a cost‐effective elimination policy in Spain

Published:2019-12-06 Issue:4 Volume:27 Page:360-370
ISSN:1352-0504
Container-title:Journal of Viral Hepatitis
language:en
Short-container-title:J Viral Hepat

Author:

Crespo Javier¹²,Cuadrado Antonio¹²^ORCID,Perelló Christie³,Cabezas Joaquin¹²,Llerena Susana¹²,Llorca Javier⁴⁵,Cedillo Sergio⁶,Llop Elba³,Escudero María Desamparados⁷,Hernández Conde Marta³,Puchades Laura⁷,Redondo Carlos²,Fortea José I.¹²,Gil de Miguel Angel⁸,Serra Miguel A.⁷,Lazarus Jeffrey V.⁹,Calleja José Luis³

Affiliation:

1. Department of Gastroenterology and Hepatology Marqués de Valdecilla University Hospital School of Medicine University of Cantabria Santander Spain

2. Marqués de Valdecilla Research Institute (IDIVAL) s/n Calle Cardenal Herrera Oria Santander Spain

3. Department of Gastroenterology and Hepatology Hospital Universitario Puerta de Hierro, Majadahonda School of Medicine Universidad Autónoma Madrid Majadahonda Spain

4. Department of Epidemiology and Computational Biology School of Medicine University of Cantabria Santander Spain

5. CIBER Epidemiología y Salud Pública (CIBERESP) IDIVAL s/n Santander Spain

6. Outcomes Research Department Chiltern International/MSD Tres Cantos Spain

7. Gastroenterology and Hepatology Servicio Medicina Digestiva del Hospital Clinico Universitario de Valencia (HUCV) Av. de Blasco Ibáñez Valencia Spain

8. Faculty of Health Sciences Rey Juan Carlos University Móstoles Spain

9. Barcelona Institute for Global Health (ISGlobal) Hospital Clínic University of Barcelona Barcelona Spain

Funder

Instituto de Salud Carlos III

Merck Sharp and Dohme

Asociación Española para el Estudio del Hígado

Publisher

Wiley

Subject

Virology,Infectious Diseases,Hepatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/jvh.13238

Reference43 articles.

1. The burden of liver disease in Europe: A review of available epidemiological data

2. United Nations General. Assembly Resolution A/RES/70/1. Transforming Our World: The 2030 Agenda for Sustainable Development.http://www.un.org/en/development/desa/population/migration/generalassembly/docs/globalcompact/A_RES_70_1_E.pdf. Accessed November 2018.

3. World Health Organization. Hepatitis C Fact Sheet.http://www.who.int/mediacentre/factsheets/fs164/en/. Accessed November 2018.

4. World Health Organization. Draft Global Health Sector Strategy on Viral Hepatitis 2016–2021 ‐ The First of its Kind.http://www.who.int/hepatitis/strategy2016-2021/Draft_global_health_sector_strategy_viral_hepatitis_13nov.pdf. Accessed November 2018.

5. World Health Organization. Combating Hepatitis B and C to Reach Elimination by 2030.http://apps.who.int/iris/bitstream/handle/10665/206453/WHO_HIV_2016.04_eng.pdf;jsessionxml:id=5F7B95D01C898DF2C9C537EDF5ED25D3?sequence=1. Accessed November 2018.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clinical and molecular characterization of steatotic liver disease in the setting of immune-mediated inflammatory diseases;JHEP Reports;2024-07

2. Low-to-moderate alcohol consumption is associated with increased fibrosis in individuals with metabolic dysfunction-associated steatotic liver disease;Journal of Hepatology;2024-07

3. Prevalence of HCV infection in Europe in the DAA era: Review;Liver International;2024-05-28

4. Increasing and sustaining blood-borne virus screening in Spain and Portugal throughout the COVID-19 pandemic: a multi-center quality improvement intervention;Frontiers in Public Health;2024-01-24

5. Emergency department contribution to HCV elimination in the Iberian Peninsula;International Journal of Emergency Medicine;2024-01-04